Transgenic model for the discovery of novel human secretory non-pancreatic phospholipase A2 inhibitors
- 1 July 1996
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 308 (2) , 195-203
- https://doi.org/10.1016/0014-2999(96)00257-9
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Pancreatic and synovial type phospholipases A2 in serum samples from patients with severe acute pancreatitis.Gut, 1993
- Serum phospholipase A2 enzyme activity and immunoreactivity in a prospective analysis of patients with septic shockLife Sciences, 1992
- Eicosanoid generation from antigen‐primed mast cells by extracellular mammalian 14‐kDa group II phospholipase A2FEBS Letters, 1991
- Detection of 14-kDa group II phospholipase A2 in human seminal plasmaBiochemical and Biophysical Research Communications, 1991
- Exacerbation of rat adjuvant arthritis by intradermal injection of purified mammalian 14‐kDa group II phospholipase A2FEBS Letters, 1990
- Group II phospholipase A2 mRNA synthesis is stimulated by two distinct mechanisms in rat vascular smooth muscle cellsFEBS Letters, 1990
- Interleukin-1β stimulates phospholipase A2 mRNA synthesis in rabbit articular chondrocytesBiochemical and Biophysical Research Communications, 1989
- In vivo release and clearance of rat platelet phospholipase A2Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1989
- Extracellular phospholipase A2: causative agent in circulatory collapse of septic shock?Inflammation Research, 1988
- Phospholipases in human seminal plasmaBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1974